Fc Engineered Anti-Human CA9 Antibody, CDC-Enhanced (Biobet-C090ZP) (CAT#: Biobet-C090ZP) Datasheet

CA9

Human IgG1, κ

Fc Engineered Anti-Human CA9 Antibody, CDC-Enhanced (Biobet-C090ZP) is a recombinant monoclonal Human IgG1, κ antibody against CA9. This product is a CDC enhanced antibody produced by our proprietary platform.

Kidney tumours

Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced rituximab. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.